FDA Approves Pfizer’s Abrysvo RSV Vaccine for Adults
Pfizer recently received approval from the U.S. Food and Drug Administration (FDA) for ABRYSVO®, its respiratory syncytial virus (RSV)...
Gilead Unveils Latest Liver Disease Research at AASLD 2024
Gilead Sciences is set to present over 40 research abstracts at The Liver Meeting® 2024, highlighting its commitment to...
New Study Links Antidepressant Use to Muscle Health and Cardiometabolic Risk
A recent study from AMRA Medical and the University of Oslo sheds light on the impact of antidepressants, specifically...
ArteraAI Prostate Test Now Accessible in CA
Artera, a company specializing in AI-powered cancer tests, has received a license from the California Department of Public Health,...
How To Measure ROI in Decentralized Clinical Trials
At the 2024 DPHARM conference, Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of...
Navigating Clinical Research Technology As a Study Site
In this interview, we sit down with Alisha Garibaldi, CEO of Skylight Health Research, to discuss managing clinical research...
How Geopolitical Economic Changes Are Impacting Big Pharma
Globalization has long been seen as a cornerstone of growth for the big pharma industry, enabling companies to expand...
Vabysmo Improves Vision in Underrepresented DME Populations
A recent Phase IV clinical trial named ELEVATUM has shown promising results for Vabysmo, a medication used to treat...
Oncoprism® Earns Medicare Coverage: Predicting Immunotherapy Response
Cofactor Genomics, a clinical-stage company focused on RNA analysis for precision medicine, has received national coverage from Medicare contractor...
Vertex Unveils Suzетrigine as First-in-Class Pain Inhibitor at ASAnesthesia
Vertex Pharmaceuticals will unveil its pivotal Phase 3 data for suzetrigine, a potential non-opioid treatment for moderate-to-severe acute pain,...